antibacterial agent

VANCOCIN® HCl (Vancomycin Hydrochloride for Injection USP)

VANCOCIN® HCl (Vancomycin Hydrochloride for Injection USP)

Vancocin® HCl (Vancomycin Hydrochloride for Injection USP) is a lyophilized powder, for preparing intravenous (IV) infusions, in vials each containing the equivalent of 500 mg or 1 g vancomycin base. Vancocin® HCl (Vancomycin Hydrochloride for Injection USP) is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactamresistant) staphylococci

LACILLIN® (Ampicillin preparations)

LACILLIN® (Ampicillin preparations)

Lacillin is indicated in the treatment of gastrointestinal, respiratory, systemic and urogenital infections caused by or associated with pathogens sensitive to ampicillin therapy. These infections include biliary-tract infections, bronchitis, endocarditis, epiglottitis, gonorrhea, listeriosis, meningitis, otitis media, peritonitis,

ALCEF-SB (Ceftriaxone Sodium & Sulbactam for Injection 1.5g)

ALCEF-SB (Ceftriaxone Sodium & Sulbactam for Injection 1.5g)

Ceftriaxone is a 2-aminothiazolyl methoxylmino third-generation cephalosporin derivative. Ceftriaxone, a bactericidal antimicrobial, inhibits bacterial cell wall synthesis of actively dividing cells by binding to one or more penicillin-binding proteins (PBPs). These proteins are associated with the bacterial cell membrane and probably serve in synthesis.

CIPRO IV® (ciprofloxacin) injection

CIPRO IV® (ciprofloxacin) injection

CIPRO IV (ciprofloxacin) is a synthetic antimicrobial agent for intravenous (IV) administration. The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV (both Type II topoisomerases), which are required for bacterial DNA replication, transcription, repair, and recombination.